FDA Inspection 1010228 — ITxM Clinical Services
The FDA completed an inspection of ITxM Clinical Services on March 30, 2017 in Rosemont, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 30, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Rosemont, IL (United States)